1MOSES J W, LEON M B, POPMA J J, et al. Sirolimus eluting stents versus standard stents in patients with stenosis in a native coronary artery[J]. N Engl J Med, 2003, 349:1315- 1323.
2STONE G W, ELIAS S G, COX D A, et al. A polymer based, paclitaxeleluting stent in patients with coronary artery disease[J]. N Engl J Med, 2004, 350:221-231.
3SIANOS G, HOFMA S, LIGTHART J M, et al. Stent fracture and restenosis in the drug-eluting stent era[J]. Catheter Cardiovasc lnterv, 2004, 61:111-116.
4HAI.KIN A, CARLIER S, LEON M B. Late incomplete lesion coverage following Cypher stent deploy ment for diffuse right coronary artery stenosis[J].Heart, 2004, 90:e45 -45.
5SHITE J, MATSUMOTO D, YOKOYAMA M. Sirolimus eluting stent fracture with thrombus, visualization by optical coherence tomography[J]. Eur Heart J, 2005, 24:24-24.
6MIN P K, YOONY W, KWON H K. Delayed strut fracture of sirolimus eluting stent: a significant prob lem or an occasional observation? [J]. Int J Cardiol, 2006, 106:404-406.
7SURMELY J F, KINOSHITA Y, DASH D, et al. Stent strut fracture induced restenosis in a bifurcation lesion treated with the crush stenting technique[J].Circ J, 2006, 70:936-938.
8LEMOS P A, SAIA F, LIGTHART J M, et al. Coronary restenosis after sirolimus-eluting stent implanta tion: morphological description and mechanistic analy sis from a consecutive series of cases[J]. Circulation, 2003, 108:257-260.
9CHOWDHURY P S, RAMOS R G. Images in clini cal medicine. Coronarystent fracture [J]. N Engl J Med, 2002, 347:581-581.
10BRILAKIS E S, MANIV C, WAHL M, et al. Un stable angina due to stent fracture[J].J Invasive Cardiol, 2004, 16:545-546,568.
同被引文献21
1SPINLER S A,HILLEMAN D E,CHENG J W,et al.New recommendations from the 1999 American College of Cardiology/American Heart Association acute myocardial infarction guidelines[J].Ann Pharmacother,2001,35:589-617.
2FOX K,GARCIA M A,ARDISSINO D,et al.Guidelines on the management of stable angina pectoris; the experts of the European Society of Cardiology on the management of stable angina pectoris[J].Kardiol Pol,2006,64:823-880.
3DAWKINS K D,GERSHLICK T,DE BELDER M,et al.Percutaneous coronary intervention:recommendations for good practice and training[J].Heart,2005,DEC 91(Suppl 6):vi1-27.
4American College of Cardiology; American Heart Association Task Force on Practice Guidelines[J].Cather Cardiovasc Interv,2008,71:E1-40.
5PERSHUKOV I V,BATYRALIEV T A.ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention.Part Ⅲ[J].Kardiologiia,2006,46:92-107.
6KAMATH K R,BARRY J J,MILLER K M,et al.The TAXUS drug-eluting stent:a new paradigm in controlled drug delivery[J].Adv Drug Deliv Rev,2006,58:412-436.
7BABAPULLE M N,JOSEPH L,BELISLE P,et al.A hierarchical Bayesian meta-analysis of randomized clinical trials of drug-eluting stents[J].Lancet,2004,364:583-591.
8HIATT B L,IKENO F,YEUNG A C,et al.Drug-eluting stents for the prevention of restenosis:in quest for the Holy Grail[J].Catheter Cardiovasc,2002,55:409-417.
9STONE G W,ELLIS S G,CANNON L,et al.For the TAXUS V Investigators.Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease.A randomized controlled trial[J].JAMA,2005,294:1215-1223.
10SPAULDING C,HENRY P,TEIGER E,et al.Sirolimus-eluting versus uncoated stents in actue myocardial infarction[J].N Eng L Med,2006,355:1093-1104.
